White label – Pompe disease - ClinicalTrials.eu

Resistance Training to Preserve Thigh Muscle Volume in Adults with Obesity Treated with Tirzepatide (Phase IV Randomized Trial)

Recruiting

3 1 1 1
Investigated Drugs:
- Tirzepatide
A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Recruiting

3 1 1
Investigated Drugs:
- Azd5004
- Dapagliflozin
+1
Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Recruiting

3 1 1
Investigated Drugs:
- Golimumab
- Guselkumab
+9
Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

Recruiting

3 1 1
Investigated Drugs:
- Golimumab
- Guselkumab
+11
Effect of Lepodisiran on Coronary Plaque in Adults with Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease or High Risk for First Event

Recruiting

3 1
Investigated Diseases:
- Arteriosclerosis
Investigated Drugs:
- Ly3819469 Sodium
Study of tasimelteon compared to placebo for treating insomnia in children

Recruiting

3 1 1
Investigated Drugs:
- Tasimelteon
Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

Recruiting

3 1
Investigated Diseases:
- Obesity
Investigated Drugs:
- Azd5004
Safety and Efficacy of BMS-986528 with Tocilizumab in Patients with Refractory Rheumatoid Arthritis: A Phase 1/2a Open‑Label Study

Recruiting

2 1 1 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Tocilizumab
Study of LY3484356 (imlunestrant) with Tamoxifen Citrate and Goserelin Acetate in Premenopausal Women with ER‑Positive, HER2‑Negative Early Breast Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Breast neoplasm
Investigated Drugs:
Randomized Controlled Trial Assessing Dermal Bioequivalence of Two Doxepin Hydrochloride Creams in Healthy Volunteers

Recruiting

1 1 1 1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies